Also found in: Medical.
HMPAOTc-Hexamethylpropyleneamine Oxime (radiophamaceutical tracer compound)
References in periodicals archive ?
The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.
This study was done to determine an association between chronic tobacco use and changes in cerebral perfusion (hypoperfusion or hyperperfusion), through semi-quantitative scintigraphic assessment employing Tc-99m HMPAO SPECT PATIENTS AND METHODS The research project was conducted at the Department of Medical Sciences, P.
Brain single-photon emission tomography with 99mTc HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations.
HMPAO SPECT brain imaging and low pressure HBOT in the diagnosis and treatment of chronic traumatic, ischemic, hypoxic and anoxic encephalopathies.
The results, obtained using Tc-99m HMPAO SPECT scans, also showed similarities between chronic fatigue syndrome and fibromyalgia.
HMPAO gained Food and Drug Administration (FDA) approval in 1990; MCG begain doing brain SPECT scans for epileptic focus localization in 1993.
Interactive three dimensional region of interest analysis of Tc-99m HMPAO SPECT brain images.
Each subject received an age/weight-appropriate dose of Tc99m HMPAO intravenously.
In children, Tc 99m HMPAO is preferred over other scintigraphic techniques because its overall radiation dose is lower.
Improved detection of cerebral hypoperfusion with internal carotid balloon test occlusion and 99mTc HMPAO cerebral perfusion SPECT imaging.